stockrowKiniksa Pharmaceuticals International, plc (KNSA) vs Lantheus Holdings, Inc. (LNTH)
- Kiniksa Pharmaceuticals International, plc KNSA 94.01 +6.42%
- Lantheus Holdings, Inc. LNTH 100.65 −0.05%
Kiniksa Pharmaceuticals International, plc and Lantheus Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Kiniksa Pharmaceuticals International, plc and Lantheus Holdings, Inc. are of similar size ($6.9B and $6.6B). Lantheus Holdings, Inc. trades at the lower P/E: 24.3× against 62.1×. Kiniksa Pharmaceuticals International, plc grew revenue faster over the last twelve months: 58.2% against 2.38%. Lantheus Holdings, Inc. has the higher net margin (17.3% vs 11.6%) and the lower return on invested capital (14.6% vs 57.7%). Across the 20 metrics below, Lantheus Holdings, Inc. leads on 12 and Kiniksa Pharmaceuticals International, plc on 8.
Valuation
Profitability
| Metric | KNSA | LNTH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 90.16% | 61.26% | 53.51% |
| Operating margin | 13.79% | 18.62% | 0.00% |
| Net margin | 11.58% | 17.28% | (2.45%) |
| Free cash flow margin | 20.85% | 26.21% | 0.00% |
| Return on equity | 17.59% | 21.81% | (0.80%) |
| Return on assets | 12.92% | 11.41% | (1.67%) |
| Return on invested capital | 57.65% | 14.62% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack